Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on Repligen, Lowers Price Target to $200

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $230 to $200.
byBenzinga Newsdesk
January 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $230 to $200.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0